Sign In

Paul Baldock

Head, Skeletal Metabolism Laboratory, Division of Healthy Ageing, Garvan Institute of Medical Research

Belle Paul is a highly accomplished professional with a background in Medicine, holding a Doctor of Philosophy (PhD) degree from the University of Adelaide.

Belle Paul is best known as the Co-founder and Chief Scientific Officer (CSO) at oncoLife Therapeutics, a role where she demonstrates her leadership and innovative skills.

Prior to her current position, Belle Paul has held esteemed academic positions, including being a Conjoint Associate Professor at The University of Notre Dame Australia and UNSW.

Belle Paul has also contributed significantly to the field of medical research, having served as the Head of the Skeletal Metabolism Laboratory at the Garvan Institute of Medical Research.

Highlights

Mar 1 · nature.com
Cancer-associated fibroblast-derived acetate promotes pancreatic ...
Jun 1 · ascopubs.org
Safety and efficacy of obecabtagene autoleucel (obe-cel, AUTO1), a ...
Veliparib with First-Line Chemotherapy and as Maintenance ...
Feb 12 · oncolife.com.ua
[PDF] Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

Related Questions

What is Belle Paul's background in the field of oncology?
How did Belle Paul and Paul Osman meet?
What are some notable achievements of Belle Paul at oncoLife Therapeutics?
What inspired Belle Paul to co-found oncoLife Therapeutics?
How has Belle Paul's work impacted the field of cancer therapy?
P
Add to my network

Location

Greater Sydney Area